EOFLOW Co.,Ltd.

KOSDAQ 294090.KQ

EOFLOW Co.,Ltd. Price to Earnings Ratio (P/E) on January 14, 2025: -1.52

EOFLOW Co.,Ltd. Price to Earnings Ratio (P/E) is -1.52 on January 14, 2025, a 26.64% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

EOFLOW Co.,Ltd. 52-week high Price to Earnings Ratio (P/E) is -1.30 on December 09, 2024, which is 14.57% above the current Price to Earnings Ratio (P/E).
EOFLOW Co.,Ltd. 52-week low Price to Earnings Ratio (P/E) is -7.46 on May 21, 2024, which is -390.81% below the current Price to Earnings Ratio (P/E).
EOFLOW Co.,Ltd. average Price to Earnings Ratio (P/E) for the last 52 weeks is -3.32.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

KOSDAQ: 294090.KQ

EOFLOW Co.,Ltd.

CEO	Mr. Jaejin Kim
IPO Date	Sept. 14, 2020
Location	South Korea
Headquarters	Healthcare Innovation Park Number H2102
Employees	121
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

EOFLOW Co.,Ltd. develops and provides drug delivery solutions. The company offers EOPatch, a wearable insulin pump system. EOFLOW Co.,Ltd. is based in Seongnam, South Korea.

Key trends

Past 5 years